Previous Close | 7.62 |
Open | 7.49 |
Bid | 7.16 x 1000 |
Ask | 7.45 x 900 |
Day's Range | 6.93 - 7.71 |
52 Week Range | 5.11 - 31.35 |
Volume | |
Avg. Volume | 111,879 |
Market Cap | 159.551M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for APGN
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
SAN CARLOS, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc. (NASDAQ: APGN) a clinical-stage company focused on developing innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology, today announced that the Company’s Management will participate virtually in the Wedbush PacGrow Healthcare Conference on Tuesday, August 9, 2022. 2022 Wedbush PacGrow Healthcare ConferenceFormat: Panel discussion and one-on-one investor meetingsTopic: For Your IOnly -